Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
David Boothman

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

David Boothman, Ph.D.

 Personal Overview

Biographical Sketch Details of Research Personal Overview How to Contact
David Boothman
Name:
  David Allen Boothman, Ph.D.
Endowed Title:
  Robert B. and Virginia Payne Professorship in Oncology
Academic Title:
  Professor
Primary Appointment:
  Simmons Comprehensive Cancer Center
Secondary Appointment:
  Pharmacology
School:
  Southwestern Medical School
Degree Program:
  Genetics and Development
Affiliations:
  Hamon Center for Therapeutic Oncology
Komen Alliance Breast Cancer Research
Moncrief Radiation Oncology Center
Radiation Oncology
Simmons Comprehensive Cancer Center
Department Website:
  Simmons Cancer Center
Lab Website:
  Boothman Laboratory Website
Email:
  David Boothman, Ph.D.

 PERSONAL OVERVIEW
     
Research in the laboratory of Dr. David A. Boothman examines cellular responses to DNA damage caused by therapeutic agents. Ionizing radiation (Ir) is a major therapeutic modality used for treating nearly all cancers. Yet, gene expression responses that afford sensitivities/resistance to this agent are still unresolved. Cellular responses under investigation are: signal transduction processes, gene/protein expression changes, post-translational regulation affecting function, cellular and molecular biology of apoptosis, and cellular and molecular biology of cancer and aging. Research in the lab is separated into four main areas:
i) Cellular and molecular biology of damage-inducible gene expression
ii) Cellular and molecular biology of non-homologous end joining (NHEJ) DNA double strand break repair. Proteins, such as nuclear clusterin and Ku70 Binding Protein 35, involved in NHEJ are being cloned, characterized, and functions revealed.
iii) Development and use of novel β-lapachone derivatives; chemotherapeutic and chemopreventive agents for the treatment of cancer
iv) Role of DNA mismatch repair (MMR) in retrograde (nucleus-to-cytoplasm) signaling of G2/M cell cycle checkpoint control and apoptosis
The ultimate goal of our research is to understand molecular stress responses that occur in tumor versus normal cells and to use this information to improve therapy.
 
 INTERESTING LINKS
 
   Department Website: Simmons Cancer Center
   Lab Website: Boothman Laboratory Website